search
Back to results

TElemedicine to Replace Face-to-face Physician Consultation in Patients With HyperTension : a Pilot Randomized-controlled Trial (SATE-HT)

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
telemedicine
usual care
Sponsored by
Chinese University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • have a diagnosis of essential hypertension (HT) and are currently taking antihypertensive agents
  • have good control of clinic BP as confirmed on ambulatory blood pressure monitoring (ABPM) (daytime BP ≤135/85mmHg)
  • can read basic Chinese (as the content of the app in Chinese)
  • have a home BP monitor (HBPM)
  • used any mobile app (not HT-related) in the previous 1 year

Exclusion Criteria:

  • an inability to give informed consent
  • unwillingness to conduct HBPM or repeated ABPM
  • current use of any other HT app for BP monitoring
  • relative contraindications to ABPM (diagnosed atrial fibrillation, occupational drivers or patients with bleeding tendencies)
  • severe mental illness, including those diagnosed with schizophrenia, dementia or as being actively suicidal, because these patients may have diminished ability to use the HT app;
  • a diagnosis of other chronic disease(s) that need regular physical assessments and doctors' consultations (e.g. diabetes and asthma that are being treated, but patients with hypertension and hyperlipidaemia will remain eligible)
  • diagnosed active cancer,

Sites / Locations

  • Lek Yuen Clinic and Fanling clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

telemedicine group

usual care

Arm Description

The HT app (HealthCap) allows patients to record their home BP measurements (HBPM) and can automatically provide mean BP values from the previous 7 or 30 days. 1-2 week prior to a scheduled physician, HealthCap and a research assistant will remind patients to take dual BP readings both in the morning and evening for 1 week for doctors' management. The mean values of the 7-day home BP will be checked before the index consultation. If the home BP control was optimal (i.e. ≤135/85 mmHg), other important parameters will be checked automatically by a questionnaire in the app: (i) if they have good drug compliance and if they experienced any side effects,(ii) if they have symptoms suggestive of target organ damages such as chest pain or hemiplegia, and (iii) if they have any problem(s) that need to consult a physician. If no complaints are identified, the patient can collect medications directly from the clinic and the physician appointment will be deferred for 3 months

Patients in the usual care group will be asked to refrain from downloading or using any health care apps related to HT

Outcomes

Primary Outcome Measures

rate of recruitment
number of patients recruited per month during the recruitment period
rate of retention
number of dropouts during the 6-month study period
acceptability
interview of around 20 patients in the intervention group

Secondary Outcome Measures

blood pressure levels on 24-hour ambulatory blood pressure
daytime, nighttime, and 24-hour systolic and diastolic blood pressure
healthcare utilization
number of visits to general outpatient clinic, specialist clinic(s) and hospitalization during study period
self-efficacy scale
5-item self-efficacy scale specific to hypertension; a mean score from the items of a 9 or above were classified as having good self-efficacy
medication and diet adherence
Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH); Score was summed to give a total range, higher score represented better adherence
exercise level
Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ); higher scores represented higher exercise level
eHealth literacy
Chinese 8-item eHealth literacy scale; higher scores represented higher eHealth literacy
health literacy
3-item Brief Health Literacy; higher scores represented higher health literacy

Full Information

First Posted
September 2, 2020
Last Updated
March 7, 2022
Sponsor
Chinese University of Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT04542564
Brief Title
TElemedicine to Replace Face-to-face Physician Consultation in Patients With HyperTension : a Pilot Randomized-controlled Trial
Acronym
SATE-HT
Official Title
Safety, Feasibility and Acceptability of Using TElemedicine to Replace Face-to-face Physician Consultation in Patients With HyperTension in Hong Kong: a Pilot Randomized-controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
October 7, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese University of Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators has developed a blood pressure telemonitoring system. It is hypothesized that, when optimal control of BP is confirmed on the telemonitoring system, the index physician's consultation can be safely deferred, and medications can still be prescribed without such face-to-face consultation. Despite potentially resource-saving for doctors and time-saving for patients, the feasibility and patients' acceptability of the use of the telemonitoring system to replace face-to-face physician consultation remains unclear. For primary outcome, the investigators hypothesize that this telemonitoring system will be feasible and acceptable to patients and can replace physicians' face-to-face consultations. For secondary outcomes, the investigators hypothesize that patients receiving care through telemonitoring have non-inferior BP control when compared with patients receiving usual care. Furthermore, the patients receiving telemonitoring may also have enhanced self-efficacy and compliance to drugs and lifestyle interventions

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
telemedicine group
Arm Type
Experimental
Arm Description
The HT app (HealthCap) allows patients to record their home BP measurements (HBPM) and can automatically provide mean BP values from the previous 7 or 30 days. 1-2 week prior to a scheduled physician, HealthCap and a research assistant will remind patients to take dual BP readings both in the morning and evening for 1 week for doctors' management. The mean values of the 7-day home BP will be checked before the index consultation. If the home BP control was optimal (i.e. ≤135/85 mmHg), other important parameters will be checked automatically by a questionnaire in the app: (i) if they have good drug compliance and if they experienced any side effects,(ii) if they have symptoms suggestive of target organ damages such as chest pain or hemiplegia, and (iii) if they have any problem(s) that need to consult a physician. If no complaints are identified, the patient can collect medications directly from the clinic and the physician appointment will be deferred for 3 months
Arm Title
usual care
Arm Type
Placebo Comparator
Arm Description
Patients in the usual care group will be asked to refrain from downloading or using any health care apps related to HT
Intervention Type
Device
Intervention Name(s)
telemedicine
Intervention Description
a mobile app and telemedicine platform to confirm good blood pressure control and may save doctor face-to-face consultation
Intervention Type
Other
Intervention Name(s)
usual care
Intervention Description
These patients have unrestricted access to healthcare resources such as general outpatient clinics and emergency departments
Primary Outcome Measure Information:
Title
rate of recruitment
Description
number of patients recruited per month during the recruitment period
Time Frame
baseline
Title
rate of retention
Description
number of dropouts during the 6-month study period
Time Frame
baseline, 6-month
Title
acceptability
Description
interview of around 20 patients in the intervention group
Time Frame
at 6-month
Secondary Outcome Measure Information:
Title
blood pressure levels on 24-hour ambulatory blood pressure
Description
daytime, nighttime, and 24-hour systolic and diastolic blood pressure
Time Frame
baseline, 6-month
Title
healthcare utilization
Description
number of visits to general outpatient clinic, specialist clinic(s) and hospitalization during study period
Time Frame
6-month
Title
self-efficacy scale
Description
5-item self-efficacy scale specific to hypertension; a mean score from the items of a 9 or above were classified as having good self-efficacy
Time Frame
baseline, 6-month
Title
medication and diet adherence
Description
Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH); Score was summed to give a total range, higher score represented better adherence
Time Frame
baseline, 6-month
Title
exercise level
Description
Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ); higher scores represented higher exercise level
Time Frame
baseline, 6-month
Title
eHealth literacy
Description
Chinese 8-item eHealth literacy scale; higher scores represented higher eHealth literacy
Time Frame
baseline, 6-month
Title
health literacy
Description
3-item Brief Health Literacy; higher scores represented higher health literacy
Time Frame
baseline, 6-month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: have a diagnosis of essential hypertension (HT) and are currently taking antihypertensive agents have good control of clinic BP as confirmed on ambulatory blood pressure monitoring (ABPM) (daytime BP ≤135/85mmHg) can read basic Chinese (as the content of the app in Chinese) have a home BP monitor (HBPM) used any mobile app (not HT-related) in the previous 1 year Exclusion Criteria: an inability to give informed consent unwillingness to conduct HBPM or repeated ABPM current use of any other HT app for BP monitoring relative contraindications to ABPM (diagnosed atrial fibrillation, occupational drivers or patients with bleeding tendencies) severe mental illness, including those diagnosed with schizophrenia, dementia or as being actively suicidal, because these patients may have diminished ability to use the HT app; a diagnosis of other chronic disease(s) that need regular physical assessments and doctors' consultations (e.g. diabetes and asthma that are being treated, but patients with hypertension and hyperlipidaemia will remain eligible) diagnosed active cancer,
Facility Information:
Facility Name
Lek Yuen Clinic and Fanling clinic
City
Hong Kong
Country
Hong Kong

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
May be available when inquired by other researchers

Learn more about this trial

TElemedicine to Replace Face-to-face Physician Consultation in Patients With HyperTension : a Pilot Randomized-controlled Trial

We'll reach out to this number within 24 hrs